Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Agostino Gemelli University Hospital) is a major academic research hospital located in Rome, Italy, and the second-largest hospital in Italy with 1,575 beds. Founded in 1964, it serves as the teaching hospital for the University Cattolica del Sacro Cuore's medical school and has evolved into one of Europe's largest private hospitals. The institution is officially designated as an IRCCS (research hospital) by the Italian Ministry of Health for two research disciplines: Personalized Medicine and Innovative Biotechnology. Gemelli operates the Clinical Trial Center (clinicaltrialcenter.it), the first spin-off created within an Italian hospital structure, which provides comprehensive clinical research services and Contract Research Organization (CRO) capabilities. The hospital currently manages over 600 active clinical trials across multiple therapeutic areas and maintains strategic partnerships with major pharmaceutical and medical device companies including Guardant Health and GE HealthCare.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Healthcare|Hospital|Clinical Research
Sub-Industry:Academic Medical Center|Research Hospital|CRO Services
SIZE & FINANCIALS
Employees:5001-10000
Founded:1964
Ownership:nonprofit
Status:operating
PIPELINE
Stage:Phase 1-4
Modalities:Clinical trials (all phases), Precision medicine diagnostics, Liquid biopsy testing, Gene therapy, Immunotherapy
Active Trials:600
Trial Phases:-
CORPORATE STRUCTURE
Parent Company:Università Cattolica del Sacro Cuore (teaching hospital affiliation)
Subsidiaries:Clinical Trial Center S.p.A. (CTC - established 2017), XBioGem (joint venture with BioRep - biobanking services), Gemelli Digital Medicine & Health (GDMH)
Key Partnerships:Guardant Health: Partnership to establish dedicated in-house liquid biopsy testing service (Guardant360® CDx) - one of first facilities in Italy housed within hospital system, GE HealthCare: Strategic collaboration in oncology, cardiology, obstetrics/gynecology, education and digital health, BioRep (Gruppo Sapio): Joint venture XBioGem for biobank creation and management, Alira Health: Collaboration agreement with Gemelli Digital Medicine & Health for digital health, Real-World Evidence (RWE) and Market Access solutions, Università Cattolica del Sacro Cuore: Academic affiliation and teaching hospital designation
COMPETITION
Position:Leader
Competitors:San Raffaele Hospital (Milan), Ospedale dell'Angelo (Mestre), IRCCS Istituto Europeo di Oncologia (Milan), Università di Padova Hospital, Major Italian academic medical centers
LEADERSHIP
Key Executives:
Daniele Franco - President of Board of Directors
Daniele Piacentini - General Director
Elena Beccalli - Rector of Università Cattolica del Sacro Cuore (nominating authority)
Scientific Founders:Agostino Gemelli (historical founder, 1964)
Board Members:Daniele Franco (President), Archbishop Mario Delpini (President of Istituto Giuseppe Toniolo di Studi Superiori - nominating authority)
LINKS
Website:clinicaltrialcenter.it
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Agostino Gemelli University Hospital. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.